Merello Elisa, Swanson Eric, De Marco Patrizia, Akhter Murtaza, Striano Pasquale, Rossi Andrea, Cama Armando, Leventer Richard J, Guerrini Renzo, Capra Valeria, Dobyns William B
Department of Neurosurgery, Gaslini Institute, Genoa, Italy.
Am J Med Genet A. 2008 May 1;146A(9):1142-50. doi: 10.1002/ajmg.a.32264.
Schizencephaly (SCH) is a rare disorder of cerebral cortical development, characterized by full thickness clefts spanning the wall of the cerebral hemispheres that are lined and surrounded by polymicrogyric cortex. Based on pathological analysis, SCH was originally considered to have multiple causes including infectious and vascular injuries, and toxic agents. However, a few reports of familial SCH have suggested a possible genetic etiology. Ten years ago two articles identified EMX2 as the first causative gene for human SCH in 13 of 18 patients, although for several putative mutations no pathogenic role was demonstrated. Here, we reinterpret the original articles as showing a significantly lower mutational rate (17%) than originally reported (72%), and provide results of EMX2 sequencing in 39 new SCH patients, detecting no pathogenic mutations. We conclude that the reported association between SCH and EMX2 mutations is not adequately supported by current data, and that diagnostic testing of EMX2 is not justified, as any results would be uninterpretable.
脑裂畸形(SCH)是一种罕见的大脑皮质发育障碍,其特征是横跨大脑半球壁的全层裂隙,裂隙内衬并被多小脑回皮质包围。基于病理分析,脑裂畸形最初被认为有多种病因,包括感染、血管损伤和有毒物质。然而,一些家族性脑裂畸形的报道提示了可能的遗传病因。十年前,两篇文章在18例患者中的13例中鉴定出EMX2是人类脑裂畸形的首个致病基因,尽管对于几个假定的突变,未证明其致病作用。在这里,我们重新解释原始文章,发现其突变率(17%)明显低于最初报道的(72%),并提供了39例新的脑裂畸形患者的EMX2测序结果,未检测到致病突变。我们得出结论,目前的数据不足以支持所报道的脑裂畸形与EMX2突变之间的关联,并且对EMX2进行诊断性检测是不合理的,因为任何结果都将无法解释。